Related Experiment Video
Updated: Jul 3, 2025
15:18
Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure
Published on: July 30, 2009
18.2K
[Risks of magistral preparations in pediatrics]
Charlotte Rosen1, Caroline Jacqmart1, Corinne Charlier1,2
1Service de Pédiatrie, CHU Liège, Belgique.
Revue Medicale De Liege
|February 15, 2024
Summary
Vasoreactive pulmonary arterial hypertension (PAH) in children requires precise dosing of oral calcium channel antagonists (CCAs). Compounding errors with CCAs can lead to severe underdosage and life-threatening cardiovascular events in pediatric patients.
Area of Science:
- Pediatric Cardiology
- Pharmacology
- Pulmonary Hypertension
Background:
- Vasoreactive pulmonary arterial hypertension (PAH) in children is treated with oral calcium channel antagonists (CCAs) to achieve pulmonary vasodilation.
- Accurate drug dosing is critical for therapeutic efficacy, especially in growing children requiring weight-based dose adjustments.
Observation:
- When low-dose pharmaceutical preparations are unavailable, compounded 'officinal' formulations become necessary.
- Compounding processes introduce potential errors in prescription, transcription, preparation, and administration of CCAs.
Findings:
- A case report details a compounding error resulting in CCA underdosage in an adolescent with vasoreactive PAH.
- This underdosage precipitated acute cardiovascular failure, highlighting the risks associated with non-standardized preparations.
Implications:
- Errors in CCA compounding can have severe, life-threatening consequences for pediatric patients with vasoreactive PAH.
- Emphasizes the need for stringent quality control and standardized protocols in preparing pediatric medications, particularly CCAs.
- Highlights the importance of careful monitoring and verification of medication preparation and administration in managing pediatric PAH.
Related Concept Videos
01:21Factors Affecting Drug Response: Overview
2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
01:24Cholinergic Antagonists: Pharmacokinetics
440
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
440
01:23Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
285
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
285
01:18Drug Delivery: Enteral Route
451
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
451
01:24Parenteral Anesthetics: Overview
125
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
125
01:19Pharmacovigilance
833
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
833